SCHEMBL7753529

SCHEMBL7753529

CCC(NC(=O)CO)C(=O)O

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MME P08473 3/20 0.42
POLB P06746 1/20 0.41
NOD1 Q9Y239 2/20 0.41
TGFBR1 P36897 3/20 0.39
KDM4E B2RXH2 1/20 0.39
MAPT P10636 1/20 0.39
THRB P10828 1/20 0.39
ALOX15 P16050 1/20 0.39
NFKB1 P19838 1/20 0.39
PTGS2 P35354 1/20 0.39
THPO P40225 1/20 0.39
RECQL P46063 1/20 0.39
BLM P54132 1/20 0.39
SMN1; SMN2 Q16637 1/20 0.39
FOLH1 Q04609 2/20 0.38
NAALAD2 Q9Y3Q0 2/20 0.38
ALDH1A1 P00352 2/20 0.38
CA2 P00918 1/20 0.37
CA4 P22748 1/20 0.37
MEN1 O00255 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2081023 0.84 CYP2C9 (0.46) MMEPOLBNOD1TGFBR1KDM4E
SCHEMBL1912625 0.84 CYP2C9 (0.46) MMEPOLBNOD1TGFBR1KDM4E
SCHEMBL1995530 0.81 TGFBR1 (0.56) MMETGFBR1KDM4EMAPTTHRB
SCHEMBL4812263 0.81 TGFBR1 (0.56) MMETGFBR1KDM4EMAPTTHRB
SCHEMBL1995531 0.81 TGFBR1 (0.56) MMETGFBR1KDM4EMAPTTHRB
SCHEMBL1133639 0.80 POLB (0.40) MMEPOLBNOD1TGFBR1KDM4E
SCHEMBL15623817 0.80 NOD1 (0.61) NOD1MEN1KMT2A
SCHEMBL2953242 0.80 POLB (0.40) MMEPOLBNOD1TGFBR1KDM4E
SCHEMBL8468722 0.80 POLB (0.40) MMEPOLBNOD1TGFBR1KDM4E
SCHEMBL974815 0.80 NOD1 (0.51) POLBNOD1MEN1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1069906-A1 CONJUGATES USEFUL IN THE TREATMENT OF PROSTRATE CANCER Merck & Co., Inc. (US) 2001-01-24 EP claimed
WO-1999044628-A1 CONJUGATES USEFUL IN THE TREATMENT OF PROSTATE CANCER MERCK & CO., INC. (US) 1999-09-10 WO claimed
CN-1181092-C Conjugates useful in treatment of prostate cancer 2004-12-22 CN disclosed